02348.HK
Dawnrays Pharmaceutical (Holdings) Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.99
−1.50%Margins
Gross margin
46.8%
EBITDA margin
25.6%
EBIT margin
17.9%
Net margin
18.1%
FCF margin
14.9%
11.9%
Return on equity
10.2%
Return on assets
11.7%
Return on invested capital
0.56x
Asset turnover
HKD 488.6M
Cash from operations
HKD 1.23
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026